Suppr超能文献

基辅针对艾滋病毒阳性和阴性患者的美沙酮维持治疗:可接受性与治疗反应

Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response.

作者信息

Dvoriak Sergii, Karachevsky Andrey, Chhatre Sumedha, Booth Robert, Metzger David, Schumacher Joseph, Chychula Nina, Pecoraro Anna, Woody George

机构信息

Director, Ukrainian Institute of Public Health Policy, 4 Malopidvalna Str. Of. 6 Kyiv, 01001 Kyiv, Ukraine.

Department of Psychiatry and Drug Abuse, O.O. Bogomolets National Medical University, 34, Peremogy Avenue, 01601 Kyiv, Ukraine.

出版信息

Drug Alcohol Depend. 2014 Apr 1;137:62-7. doi: 10.1016/j.drugalcdep.2014.01.008. Epub 2014 Jan 30.

Abstract

BACKGROUND

With up to 40% of opioid injectors infected with HIV, Ukraine has one of the most concentrated HIV epidemics in the world, mainly due to unsterile injection practices and a historical absence of effective prevention services. Harm reduction programs, including syringe exchange and a small buprenorphine treatment program, were introduced in 2004 and methadone maintenance was allowed in 2007. Despite an initial expansion, by 2009, only 3221 injectors were receiving methadone treatment. A growing body of research on methadone maintenance has found high retention rates with reduction in opioid use and HIV risk behaviors. We report on the acceptability and initial outcome of methadone treatment as a function of HIV status, an issue that has not yet been reported for injectors in Ukraine.

METHODS

Longitudinal observational study of a 12-week course of methadone treatment in 25 HIV+ and 25 HIV- opioid addicted individuals recruited from a harm reduction program and the city AIDS Center. Drug use and HIV risk were assessed at baseline and weeks 4, 8, 12 and 20; all patients were offered continued methadone maintenance in the Kyiv city program at the end of 12 weeks.

RESULTS

Fifty-four individuals were asked if they were interested in the study and 50, demographically similar to other samples of opioid addicted Ukrainians, agreed to participate. Two died of non-study related causes; the other 48 completed assessments at weeks 4, 8 and 12, and 47 completed followups at week 20. Significant reductions were seen in use of heroin (p<0.0001), other opiates/analgesics (p<0.0001), and HIV risk behaviors (drug, sex, total; all p<0.0001). All 48 patients chose to continue methadone after the 12-weeks of study medication ended. Unlike most opioid treatment studies, sexual risk was somewhat higher than injecting risk at study intake.

CONCLUSIONS

Methadone maintenance was well accepted by HIV+ and HIV- opioid dependent individuals and has the potential for significant public health impact if made more widely available with sustained access and support.

摘要

背景

乌克兰高达40%的阿片类药物注射者感染了艾滋病毒,是世界上艾滋病毒流行最为集中的地区之一,主要原因是注射操作不卫生以及长期缺乏有效的预防服务。2004年引入了减少伤害项目,包括注射器交换和一个小型丁丙诺啡治疗项目,2007年允许进行美沙酮维持治疗。尽管最初有所扩展,但到2009年,只有3221名注射者接受美沙酮治疗。越来越多关于美沙酮维持治疗的研究发现,其留存率高,阿片类药物使用和艾滋病毒风险行为减少。我们报告了美沙酮治疗的可接受性和初步结果与艾滋病毒感染状况的关系,这一问题在乌克兰注射者中尚未有报道。

方法

对从一个减少伤害项目和市艾滋病中心招募的25名艾滋病毒阳性和25名艾滋病毒阴性的阿片类药物成瘾个体进行了为期12周的美沙酮治疗纵向观察研究。在基线以及第4、8、12和20周评估药物使用和艾滋病毒风险;12周结束时,所有患者都被提供在基辅市项目中继续接受美沙酮维持治疗。

结果

询问了54人是否对该研究感兴趣,其中50人同意参与,他们在人口统计学上与其他阿片类药物成瘾的乌克兰样本相似。2人死于与研究无关的原因;其他48人在第4、8和12周完成了评估,47人在第20周完成了随访。海洛因使用(p<0.0001)、其他阿片类药物/镇痛药使用(p<0.0001)以及艾滋病毒风险行为(吸毒、性行为、总计;所有p<0.0001)均显著减少。研究用药12周结束后,所有48名患者都选择继续服用美沙酮。与大多数阿片类药物治疗研究不同的是,在研究开始时,性风险略高于注射风险。

结论

艾滋病毒阳性和艾滋病毒阴性的阿片类药物依赖个体对美沙酮维持治疗接受度良好,如果能更广泛地提供并持续获得支持,有可能对公共卫生产生重大影响。

相似文献

引用本文的文献

本文引用的文献

4
Prevention of HIV-1 infection with early antiretroviral therapy.早期抗逆转录病毒疗法预防 HIV-1 感染。
N Engl J Med. 2011 Aug 11;365(6):493-505. doi: 10.1056/NEJMoa1105243. Epub 2011 Jul 18.
5
Drug treatment as HIV prevention: a research update.药物治疗作为 HIV 预防:研究进展。
J Acquir Immune Defic Syndr. 2010 Dec;55 Suppl 1(Suppl 1):S32-6. doi: 10.1097/QAI.0b013e3181f9c10b.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验